Tada Yuji, Takiguchi Yuichi, Fujikawa Ayako, Kitamura Atsushi, Kurosu Katsushi, Hiroshima Kenzo, Sakao Seiichiro, Kasahara Yasunori, Tanabe Nobuhiro, Tatsumi Koichiro, Kuriyama Takayuki
Respirology, Chiba University.
Intern Med. 2007;46(15):1243-6. doi: 10.2169/internalmedicine.46.0146. Epub 2007 Aug 2.
A 72-year-old man with tongue carcinoma complained of dyspnea on exertion 18 days after starting treatment with S-1. Chest radiograph and CT scan suggested diffuse interstitial lesions with ground glass opacity on both lungs. Bronchoalveolar lavage and transbronchial lung biopsy revealed moderate lymphocyte infiltration with granuloma. Drug lymphocyte stimulation test was positive against tegafur, one of the components of S-1. These findings were consistent with S-1-induced lung injury. Both his symptoms and the radiographic findings were resolved dramatically after high-dose corticosteroid therapy. Clinicians should be aware that S-1 has the potential to cause lung injury when it is included in chemotherapy.
一名72岁的舌癌男性患者在开始服用S-1治疗18天后出现劳力性呼吸困难。胸部X线片和CT扫描提示双肺弥漫性间质病变伴磨玻璃影。支气管肺泡灌洗和经支气管肺活检显示中度淋巴细胞浸润伴肉芽肿形成。药物淋巴细胞刺激试验对S-1的成分之一替加氟呈阳性。这些发现符合S-1诱导的肺损伤。大剂量糖皮质激素治疗后,他的症状和影像学表现均显著缓解。临床医生应意识到,S-1用于化疗时有可能导致肺损伤。